Phase 3
Idiopathic Pulmonary Fibrosis
Intervention Type
Inhaled Drug
Funder Type

Drug Details

iNO stands for Inhaled Nitric Oxide. Nitric oxide is a colorless gas that is formed by the oxidation of nitrogen.

Study Purpose

A phase 3, randomized, double-blind, placebo-controlled dose escalation and verification clinical study to assess the safety and efficacy of pulsed inhaled nitric oxide (iNO) versus placebo in subjects at risk for pulmonary hypertension associated with pulmonary fibrosis on long term oxygen therapy. (REBUILD)

Find a Clinical Trial


footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >